EUVIMEDEUVIMED entdecken
Crossref

NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome

Blandine Monjarret, Sara Shour, Daniela Stanga, Aissa Benyoucef, Emilie Heckel, Lorie Marchitto, Jennifer W Leiding, Guilhem Cros, Isabel Fernandez, Jean-Sebastien Joyal, Fabien Touzot

Journal of Allergy and Clinical Immunology · 2026-03 · 157 (3) · 711-721.e5

DOI: 10.1016/j.jaci.2023.09.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-03. Verfasst von Blandine Monjarret und 10 weiteren Autor:innen. Beteiligte Einrichtung: CHU Sainte-Justine Research Center, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, NADPH Oxidase 2, Inflammasomes, Granulomatous Disease, Chronic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Canadian Institutes of Health Research, Fonds de Recherche du Québec - Santé, Canadian Allergy, Asthma and Immunology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Nicotinamide adenine dinucleotide phosphate oxidase complex 2 (NOX2) deficiency, or chronic granulomatous disease (CGD), is an inborn error of immunity associated with increased susceptibility to infection and inflammatory manifestations. The pathophysiologic mechanism leading to the increased inflammatory response in CGD remains elusive. OBJECTIVE: We investigated the pathophysiologic mechanisms leading to NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation in NOX2 deficiency. METHODS: We used NOX2-deficient human primary and CRISPR-engineered macrophages to show that NOX2 deficiency enhances the inflammatory response mainly by modulating the 2 steps of NLRP3 inflammasome activation: its transcriptional priming and its posttranslational triggering. RESULTS: At the transcriptional level, NOX2-deficient phagocytes display increased priming of the NLRP3 inflammasome, as evidenced by increased transcription of NLRP3 and IL-1β through an IL-1β-dependent stimulation of the nuclear factor kappa-light-chain enhancer of activated B cells (aka NF-κB) pathway. At the posttranslational level, the absence of NOX2 triggers the NLRP3 inflammasome activation by increased K+ efflux and excessive release of mitochondrial DNA due to mitochondrial damage. Furthermore, NLRP3-driven pyroptosis in NOX2-deficient phagocytes further enhances NLRP3 activation by increasing K+ efflux. CONCLUSION: Our results unveil the role of NOX2 as a repressor of the inflammatory response at both transcriptional and posttranslational levels and pave the way for a more targeted approach to treating CGD patients with inflammatory manifestations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinNADPH Oxidase 2InflammasomesGranulomatous Disease, ChronicMacrophagesHumansInterleukin-1betaNF-kappa BMitochondria

Stichwörter der Autor:innen

K(+) effluxNLRP3NOX2gasdermin Dmitochondrial damagereactive oxygen species

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNADPH Oxidase 2InflammasomesCYBB protein, humanInterleukin-1betaNLRP3 protein, humanNF-kappa B

Autor:innen und Institutionen

  • CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • CHU Sainte-Justine Research Center, Montreal, Quebec, Canada; Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.
  • Pediatric Infectious Disease and Immunology Arnold Palmer Hospital for Children at Orlando Health, Orlando, Fla; Department of Pediatrics, Division of Allergy and Immunology, Johns Hopkins University, Baltimore, Md.
  • Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada.
  • Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.
  • CHU Sainte-Justine Research Center, Montreal, Quebec, Canada; Department of Pathology and Cellular Biology, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada; Department of Pediatrics, Faculty of Med…

Förderung

  • Canadian Institutes of Health Research
  • Fonds de Recherche du Québec - Santé
  • Canadian Allergy, Asthma and Immunology Foundation

Zitieren

APA

Monjarret, B., Shour, S., Stanga, D., Benyoucef, A., Heckel, E., Marchitto, L., Leiding, J. W., Cros, G., Fernandez, I., Joyal, J. S., & Touzot, F. (2026). NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome. Journal of Allergy and Clinical Immunology, 157(3), 711-721.e5. https://doi.org/10.1016/j.jaci.2023.09.030

Vancouver

Monjarret B, Shour S, Stanga D, Benyoucef A, Heckel E, Marchitto L, et al. NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome. Journal of Allergy and Clinical Immunology. 2026;157(3):711-721.e5. doi:10.1016/j.jaci.2023.09.030

BibTeX
@article{Monjarret2026,
  author = {Monjarret, Blandine and Shour, Sara and Stanga, Daniela and Benyoucef, Aissa and Heckel, Emilie and Marchitto, Lorie and Leiding, Jennifer W and Cros, Guilhem and Fernandez, Isabel and Joyal, Jean-Sebastien and Touzot, Fabien},
  title = {NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  volume = {157},
  number = {3},
  pages = {711--721.e5},
  doi = {10.1016/j.jaci.2023.09.030}
}
Kostenlos starten →